Endorsed Event: London Live Endoscopy
- 9:00 am - 1:30 pm
We’re delighted to be holding a special webinar to celebrate the 60th Anniversary of ‘Gut’ with guest speakers sharing their experiences and insights about being published in medical journals.
The webinar will be Chaired by Alastair McKinlay, President of BSG and Anton Emmanuel, BSG Treasurer. This webinar is free to BSG members; you will need to log into your BSG account to book your ticket. Please note that when you book your place, you need to add the ticket to the ‘basket’ using the + button.
Questions and comments can be posted in the ‘chat’ facility and as many of these as possible will be answered by the panel during the webinar. Following the webinar, the video replay will be sent out.
A previous Editor of Gut, Prof Spiller will give a historical perspective describing the first issues and pick out a selection of papers which caught his attention over the subsequent 60 years. Many papers have been “ground breaking”, leading to significant developments in the field. This talk will feature some of the papers that have helped move the gastroenterology profession forwards.
Prof el-Omar is the current Editor of Gut. His talk addresses the question of why publish, and is “publish or perish” a valid notion? His talk also looks at how to maximise the quality of your research, strategies for getting published and finally, how to handle rejection.
Prof Julia Mayerle’s talk will look at Gut’s major achievements in scientific publishing in the last 60 years,how to maintain quality, develop best practice standards and how do we imagine scientific publishing in the future – doomed to extinction?? She will also examine the role of scientific publishing during a pandemic.
NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham
Past Editor of Gut (2003-2009) and member of the Board of the Rome Foundation (2000-2015), he twice edited the British Society of Gastroenterology ( BSG )Guidelines for the management of IBS. His main research interest is the pathophysiology of irritable bowel syndrome(IBS), particularly the role of infection, inflammation, diet and alterations in the microbiome. He also has a long-standing collaboration with the Sir Peter Mansfield Imaging Centre pioneering the use of MRI to image the processes of digestion with a particular focus on mechanisms in functional bowel diseases and food intolerance. Author/co-author of more than 408 widely cited scientific reviews and original publications. Current interests include the mode of action of ondansetron in treating IBS with diarrhoea, using MRI to predict response to treatment of IBS with constipation and the effect of fibre on intestinal physiology in IBS.
Editor in Chief, GUT. Director, Microbiome Research Centre, St George & Sutherland Clinical School
Professor El-Omar graduated in Medicine from Glasgow University, Scotland, and trained as a gastroenterologist. He worked as a Visiting Scholar/Scientist at Vanderbilt University, TN, and National Cancer Institute, MD, USA, and was Professor of Gastroenterology at Aberdeen University, Scotland, for 16 years before taking up the Chair of Medicine at St George & Sutherland Clinical School, University of New South Wales, Sydney, Australia. He is the Editor in Chief of the journal Gut. His research interests include all aspects of the microbiome, inflammation driven GI cancer and IBD. He is the Director of the Microbiome Research Centre at UNSW/St George Hospital, Sydney.
Prof Meyerle mostly sees patients with pancreatic disorders ranging from pancreatitis to cancer and as a researcher was trained to participate in basic science projects as well as clinical projects ranging from randomized clinical trials to interventional endoscopy. During her trainingshe spent time in laboratories focusing on pancreatic cancer (at Berne and UCL Irvine), cell biology (UCLA), and interventional endoscopy (Lister fellow, Glasgow).. The benefits of serving as a department chair at the University of Munich, whose internationally top ranked medical school, includes the opportunity to transfer experimental research results directly into multicentre clinical trials (e.g. the META-PAC trial or MagPEP Trial NCT00142233). The principal focus of her grants involve the immunological response in pancreatitis and the role of early detection and treatment resistance in pancreatic cancer.
Please note that when you book your place, you need to add the ticket to the ‘basket’ using the + button.